Jim Tananbaum’s Legendary Success Accelerating Biotech Startups

Foresite Capital is a venture capital firm providing funding to healthcare startups with a strong focus on biotechnology. It offers growth capital to startups with disruptive solutions in the healthcare industry including devices, diagnostics and therapeutic services. The firm was founded in 2011 in San Francisco, California by the current CEO and Managing Director, Jim Tananbaum. Foresite Capital also has a presence in New York and is believed to hold over $1.3 billion in assets under its management.

Recently the firm added a new Venture Partner to its stable, Dr. Molly He. Molly has over 15 years’ experience in healthcare technology management and research development. Before the position at Foresite Capital, she worked as a senior scientific research director at Illumina, a publicly listed healthcare technology services company in San Diego, CA, focused on biotechnology including molecular biology and drug development. Before Illumina, she worked for Pacific Biosciences, a biotech company based in California.

Molly has extensive technical expertise and an outstanding track record of excellent leadership. She is an invaluable addition to the Foresite team assisting in the expansion and diversification of pioneering assets. Molly He is a biochemistry graduate of Nankai University. She also has a biophysics Ph.D. from the University of California. Besides, she is a published author of more than twenty journals and read full article.

In addition, she has over 20 combined patents, both issued and pending. According to Jim Tananbaum, she brings a wealth of experience in next-gen genome sequencing and customized medicine that makes her a highly sought-after scientist.

Jim Tananbaum has over twenty-five years’ industry experience in the biotech space. He has a science degree and a master’s degree from Yale University and MIT respectively. He is a qualified medical doctor from Harvard Medical School and also holds a business master’s degree from the Harvard Business School and learn more about Jim.

Jim Tananbaum has extensive venture capital experience. He is adept at managing venture capital funds and helping businesses raise growth capital. He has been involved in the establishment of a multitude of biotechnology and pharmaceutical companies including GelTex, Sierra Ventures, Theravance and Prospect Venture Partners. He has also been instrumental in various mergers and acquisitions in the drug industry such as Amira Pharmaceuticals, Amerigroup, and Jazz Pharmaceuticals among others and resume him.

Leave a Reply

Your email address will not be published. Required fields are marked *